NHLBI Updates Guidance for Management of Asthma
FRIDAY, Dec. 4, 2020 -- In an update to the Asthma Management Guidelines, published in the December issue of the Journal of Allergy and Clinical Immunology, new guidance is presented for asthma management and treatment, focusing on tailored treatment interventions for specific age groups based on disease severity.
Michelle M. Cloutier, M.D., from UCONN Health in Farmington, Connecticut, and colleagues from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group, supported by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health, addressed six priority topic areas to update asthma management in the clinical setting.
The updates provide guidance on use of inhaled corticosteroids for recurrent wheezing or persistent asthma; use of long-acting antimuscarinic agents with inhaled corticosteroids for long-term management of asthma; and use of allergy shots containing small amounts of allergen for some individuals with allergic asthma. In addition, guidance is provided for the use of methods to reduce exposure to indoor asthma triggers; use of the fractional exhaled nitric oxide test to help manage asthma or confirm diagnosis in some patients; and use of bronchial thermoplasty to treat selected adults with persistent asthma.
"The last national guidance on asthma care was published 13 years ago, and since then we've made substantial progress in understanding how to treat asthma in children and adults," Cloutier said in a statement. "In addition to asthma management varying by age group and disease severity, the preferences and values that individuals with asthma place on different therapies must be considered. The new guidelines reflect some of these new approaches."
Several authors disclosed financial ties to the pharmaceutical industry.
© 2021 HealthDay. All rights reserved.
Posted: December 2020
Read this next
TUESDAY, Dec. 22, 2020 -- Increased dietary advanced glycation end-product (AGE) intake is associated with wheezing symptoms in children, including wheeze-disrupted sleep and...
TUESDAY, Dec. 15, 2020 -- A substantial percentage of young patients with asthma do not comply with COVID-19 prevention measures, according to a Mexican study recently published...
MONDAY, Dec. 14, 2020 -- Prescription of asthma medications before and during pregnancy is associated with increased prevalence of adverse perinatal outcomes, especially with...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.